362 related articles for article (PubMed ID: 21787388)
1. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
[TBL] [Abstract][Full Text] [Related]
2. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
5. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.
Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F
J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640
[TBL] [Abstract][Full Text] [Related]
6. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
[TBL] [Abstract][Full Text] [Related]
7. CD147 expression in advanced cutaneous squamous cell carcinoma.
Sweeny L; Dean NR; Frederick JW; Magnuson JS; Carroll WR; Desmond RA; Rosenthal EL
J Cutan Pathol; 2012 Jun; 39(6):603-9. PubMed ID: 22575025
[TBL] [Abstract][Full Text] [Related]
8. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.
Sepponen K; Ruusunen M; Pakkanen JA; Pösö AR
Vet J; 2007 Jul; 174(1):122-8. PubMed ID: 16901736
[TBL] [Abstract][Full Text] [Related]
11. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
[TBL] [Abstract][Full Text] [Related]
12. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
[TBL] [Abstract][Full Text] [Related]
13. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.
Kirk P; Wilson MC; Heddle C; Brown MH; Barclay AN; Halestrap AP
EMBO J; 2000 Aug; 19(15):3896-904. PubMed ID: 10921872
[TBL] [Abstract][Full Text] [Related]
14. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y
Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).
de Oliveira AT; Pinheiro C; Longatto-Filho A; Brito MJ; Martinho O; Matos D; Carvalho AL; Vazquez VL; Silva TB; Scapulatempo C; Saad SS; Reis RM; Baltazar F
J Bioenerg Biomembr; 2012 Feb; 44(1):171-8. PubMed ID: 22281667
[TBL] [Abstract][Full Text] [Related]
18. Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma.
Sukeda A; Nakamura Y; Nishida Y; Kojima M; Gotohda N; Akimoto T; Ochiai A
Pancreas; 2019 Sep; 48(8):1102-1110. PubMed ID: 31404019
[TBL] [Abstract][Full Text] [Related]
19. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Gouveia C; Jerónimo C; Henrique RM; Lopes C; Baltazar F
Prostate; 2013 May; 73(7):763-9. PubMed ID: 23192371
[TBL] [Abstract][Full Text] [Related]
20. GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.
Almeida LMCA; Silva R; Cavadas B; Lima J; Pereira L; Soares P; Sobrinho-Simões M; Lopes JM; Máximo V
Histol Histopathol; 2017 Oct; 32(10):1029-1040. PubMed ID: 28028797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
